Whole‑Body MRI Screenings Grow in Popularity Even as Doctors Sound the Alarm

In the last few years, a surprising number of people have started ordering whole‑body MRI scans for themselves—no doctor’s order required, just a click on a website. The buzz largely comes from Instagram influencers and YouTube personalities who promise that a single, all‑encompassing scan can spot stage‑one cancers, hidden heart problems, or even tiny orthopedic quirks before any symptom shows up.

“They’ll scan for stage‑one cancers as well as 500 other conditions,” one popular TikTok creator exclaimed, while another added, “You deserve to know what’s happening inside you, even before you feel anything.” The message is simple: knowledge is power, and a high‑resolution picture of your body sounds like the ultimate health hack.

Companies like Prenuvo have turned this idea into a business. Their website advertises a “comprehensive health check‑up” that costs anywhere from $1,500 to $4,000, a price most insurance plans won’t cover. The company’s chief medical officer, Dan Durand, says about one in five scans uncovers something that needs a follow‑up test. “It depends on how serious the finding is and how confident we are about what it is,” he explained.

That statistic sounds reassuring at first glance, but many physicians are far less enthusiastic. Radiologist Dr. Robert Krasny of RadNet in Santa Monica points out a classic downside: the more you look, the more you’ll find—often things that never cause a problem. “The classic downside is finding something that ultimately turns out to be nothing,” he warned.

Medical societies have issued formal statements saying elective whole‑body MRIs haven’t been proven to improve survival rates. They argue that established screening programs—like mammograms for breast cancer or colonoscopies for colon cancer—are backed by decades of research showing real benefit. By contrast, broad‑spectrum scans can produce false alarms, leading patients down costly, invasive pathways that might never have been needed.

To illustrate, Dr. Krasny cited a JAMA editorial about ovarian‑cancer screening. In that study, 212 women who underwent elective screening were diagnosed with ovarian cancer, yet their death rates were identical to women who weren’t screened. Over a thousand women in the screening arm ended up having unnecessary surgery because of incidental findings.

Even so, Durand acknowledges that for some people the sheer knowledge is worth it, regardless of whether it changes outcomes. “Even if there’s no survival benefit, I’d still want to know,” he said, noting that his own family depends on him and he’d rather be informed than left in the dark.

Cost is another factor. At $1,500‑$4,000 per scan, most people pay out‑of‑pocket. That price tag can feel steep, especially when the test isn’t covered by insurance and the clinical value is still debated. “Just because something is offered doesn’t mean it’s the right test for you,” Dr. Krasny cautioned.

Still, the trend isn’t slowing down. Durand sees whole‑body MRI as part of a broader “preventive‑medicine” movement. Besides hunting for tumors, the scans sometimes reveal heart‑related issues or joint degeneration, which could be useful for people with a family history of those problems.

Both sides agree on one thing: patients need a candid conversation with their primary‑care doctors before signing up. “Talk about your personal, family, or occupational history first,” Dr. Krasny advised. “A good discussion can help you decide if the test is truly helpful or just a source of anxiety.”

In the end, the choice rests with each individual—balancing curiosity, peace of mind, and the possibility of extra tests that may never have been necessary.